<DOC>
	<DOCNO>NCT02210286</DOCNO>
	<brief_summary>The purpose study examine effect supplement Magnesium L-Threonate people mild moderate dementia . The investigator goal understand whether Magnesium L-Threonate associate improvement memory brain function .</brief_summary>
	<brief_title>Magnesium L-Threonate Enhancement Learning Memory People With Dementia</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<criteria>People either gender &gt; 60 year age . Subject score 16 26 MMSE Subject representative willing sign consent prior enrollment study participate aspect study . Prospective subject must give verbal assent unable sign write consent . Adequate visual auditory acuity allow neuropsychological testing . Greater 12 year educational achievement , General Education Development certificate allow adequate neuropsychological testing , consistency sample . Female subject surgically sterile , postmenopausal agrees use acceptable method birth control . Subject agree stop taking vitamin , mineral , dietary/herbal supplement he/she currently take least 7 day prior randomization agrees take vitamin , mineral dietary/herbal supplement study product study completion . Active heart disease Uncontrolled high blood pressure ( â‰¥ 140/90 mmHg ) Renal hepatic impairment/disease Type I diabetes Unstable thyroid disease Psychiatric disorder ( hospitalize past year ) History drug alcohol abuse . Immune disorder ( HIV/AIDS ) TIAs , carotid bruits , verify lacunes Significant pulmonary disease Contraindication PET scan include stroke heart attack past 6 month , unable unwilling lie 1 hour . Any medical condition deem exclusionary Principal Investigator ( PI ) History cancer ( except localize skin cancer without metastasis situ cervical cancer ) within 5 year prior screen . Currently take medication know interact magnesium . Currently take antibiotic study product may reduce absorption antibiotic . A washout period 2 week allow . On unstable dose medication ( define few 90 day dose ) . Currently take medication deem exclusionary PI . Allergy sensitivity ingredient test product . Evidence hepatic renal dysfunction History drug alcohol abuse past 12 month . Pregnant , lactating , plan become pregnant study period . Subject condition abnormality , opinion investigator , would compromise safety subject quality study data . Subject participate participate another research study within 30 day prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>dementia</keyword>
	<keyword>magnesium</keyword>
	<keyword>learn</keyword>
	<keyword>memory</keyword>
	<keyword>Alzheimer 's disease</keyword>
</DOC>